CIK 0002079109 · <br>Emerging growth company
Veraxa Biotech AG - Post de-SPAC
Sign in to watch- Ticker
- VRXA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41443858450
- Business address
- TALACKER 35, ZURICH, Switzerland, 8001
- Former names
- Veraxa Biotech Holding AG
Securities
- VRXA Ordinary Shares Nasdaq
- VRXAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| No insider trades stored. | ||||||